Locations:
SearchAdvertisement
A cost-effective alternative to enoxaparin?
Results of the largest population-based study to date
A negative impact despite income or education status
Guidance for evaluating and monitoring patients based on results from several studies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two-drug therapy reduces progression in rare hereditary cancer syndrome
Which cysts turn malignant and why NSAIDs can be chemoprotective
Too few patients assessed before undergoing biologic dose changes
Research suggests T2D variants with differing metabolic responses to gastric bypass
Cleveland Clinic study finds increased detection may not mean higher risk of metachronous advanced neoplasia
Method can eliminate need for liver biopsies in significant number of patients
Advertisement
Advertisement